Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
FDA supplemental approval of dexmedetomidine hydrochloride labeling; no clinical trial data or efficacy evidence reported in this regulatory action record.
FDA approval of dexmedetomidine hydrochloride generic injectable formulation; regulatory action establishing product availability but does not report clinical trial efficacy or safety data.